Mitomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 55150-450

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Mitomycin (NDC 55150-450). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mitomycin-fig1 (Mitomycin Fig1)

Label for Mitomycin for Injection, USP, 5 mg per vial, lyophilized powder for intravenous use. The single-dose vial is manufactured for Eugia US LLC, featuring warnings to avoid tissue damage and discard unused portions. Storage instructions include refrigeration and protection from light and heat.*

FDA Label Image

Mitomycin-fig2 (Mitomycin Fig2)

Packaging label for Mitomycin Injection, USP 5 mg per vial, a lyophilized powder for intravenous injection. The label includes warnings about intravenous administration to avoid tissue damage and instructions for cytotoxic special handling. Distributed by Eugia US LLC, with storage and dosage instructions noted on the box. The vial is single-dose, with unused portions discarded.*

FDA Label Image

Mitomycin-fig3 (Mitomycin Fig3)

The label for Mitomycin injection, USP, contains 20 mg per vial of mitomycin in a lyophilized powder form for intravenous use. It is a single-dose vial with warnings to avoid tissue damage. The label shows instructions for reconstitution with sterile water and storage conditions. The product is labeled by Eugia US LLC and manufactured in India.*

FDA Label Image

Mitomycin-fig4 (Mitomycin Fig4)

Label for Mitomycin for Injection, USP 20 mg per Vial, a lyophilized powder for intravenous injection. The label contains warnings about intravenous administration to avoid tissue damage and cytotoxic special handling procedures. It is distributed by Eugia US LLC and includes storage and usage instructions, a barcode, and the NDC 55150-451-01. The vial stopper is latex-free.*

FDA Label Image

Mitomycin-fig5 (Mitomycin Fig5)

Label for Mitomycin for Injection, USP, 40 mg per vial, injection powder lyophilized for intravenous use. The label includes storage instructions, usage warnings, and manufacturer Eugenia US LLC information. It specifies single-dose vial, with directions to add sterile water for solution preparation.*

FDA Label Image

Mitomycin-fig6 (Mitomycin Fig6)

Packaging label for Mitomycin for Injection, USP 40 mg per vial. The label indicates this product is for intravenous use and must be administered as such to avoid tissue damage. It is a single-dose vial that requires cytotoxic special handling. Distributed by Eugia US LLC, the label provides storage instructions and a warning that the vial stopper is not made with natural rubber latex. The label includes the NDC 55150-452-01 and mentions the product is made in India.*

FDA Label Image

Mitomycin-str (Mitomycin Str)

Chemical structure of the active ingredient mitomycin. The diagram shows the molecular arrangement with labeled functional groups and bonds characteristic of mitomycin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.